VitroVo
VitroVo helps drug discovery teams evaluate compounds in vitro to predict safety and efficacy early. It uses Micro-electrode Array (MEA) technology, including High Density MEA, to measure neurological and cardiac activity. The company offers contract testing, data analysis, joint R&D, screening, and consulting, with models from iPS-derived neurons to brain organoids and cardiomyocytes. Advanced tooling—Imaging, MPS, AI-driven data analysis, and toxicology prediction—supports clients across pharma and biotech.
VitroVo
VitroVo helps drug discovery teams evaluate compounds in vitro to predict safety and efficacy early. It uses Micro-electrode Array (MEA) technology, including High Density MEA, to measure neurological and cardiac activity. The company offers contract testing, data analysis, joint R&D, screening, and consulting, with models from iPS-derived neurons to brain organoids and cardiomyocytes. Advanced tooling—Imaging, MPS, AI-driven data analysis, and toxicology prediction—supports clients across pharma and biotech.